Michael R. Freeman

22.9k total citations · 1 hit paper
284 papers, 16.3k citations indexed

About

Michael R. Freeman is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Michael R. Freeman has authored 284 papers receiving a total of 16.3k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 72 papers in Surgery and 71 papers in Cancer Research. Recurrent topics in Michael R. Freeman's work include Prostate Cancer Treatment and Research (54 papers), Cardiac Imaging and Diagnostics (48 papers) and Cancer, Lipids, and Metabolism (43 papers). Michael R. Freeman is often cited by papers focused on Prostate Cancer Treatment and Research (54 papers), Cardiac Imaging and Diagnostics (48 papers) and Cancer, Lipids, and Metabolism (43 papers). Michael R. Freeman collaborates with scholars based in United States, Canada and United Kingdom. Michael R. Freeman's co-authors include Keith R. Solomon, Rosalyn M. Adam, Dolores Di Vizio, Jayoung Kim, Liyan Zhuang, Valentina R. Minciacchi, Paul W. Armstrong, Wei Yang, Anthony Atala and Craig A. Peters and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Michael R. Freeman

277 papers receiving 16.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes

2015 750 citations Valentina R. Minciacchi, Michael R. Freeman et al. profile →

Peers

Countries citing papers authored by Michael R. Freeman

Since Specialization

Citations

This map shows the geographic impact of Michael R. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Freeman more than expected).

Fields of papers citing papers by Michael R. Freeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Freeman. The network helps show where Michael R. Freeman may publish in the future.

Co-authorship network of co-authors of Michael R. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Freeman. A scholar is included among the top collaborators of Michael R. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Freeman. Michael R. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The homeodomain regulates stable DNA binding of prostate cancer target ONECUT2 2024 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Steve Silletti, Elizabeth A. Komives, Michael R. Freeman, Ramachandran Murali	2
2	ONECUT2 regulates RANKL-dependent enterocyte and microfold cell differentiation in the small intestine; a multi-omics study 2022 ·Nucleic Acids Research ·Maria Velez, Hannah K. Neikes, (unknown), (unknown), Qian Chen, (unknown), Gert Jan C. Veenstra, Michael R. Freeman, Simon J. van Heeringen, Michiel Vermeulen	9
3	Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis 2022 ·Nature Communications ·Yiwu Yan, Bo Zhou, Qian Chen, (unknown), Mohini Kamra, (unknown), Yeon‐Joo Lee, Xiaopu Yuan, Leigh Ellis, Dolores Di Vizio, Edwin M. Posadas, Natasha Kyprianou, Beatrice S. Knudsen, Kavita Shah, Ramachandran Murali, Arkadiusz Gertych, Sungyong You, Michael R. Freeman, Wei Yang	28
4	A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma 2021 ·Cancer Research ·Sai Ma, Bo Zhou, Qian Yang, Yunzhi Pan, Wei Yang, Stephen J. Freedland, Ling‐Wen Ding, Michael R. Freeman, Joshua J. Breunig, Neil A. Bhowmick, Jian Pan, H. Phillip Koeffler, De‐Chen Lin	60
5	Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity 2021 ·Clinical Cancer Research ·Yanping Wang, Sungyong You, Shengchen Su, Austin Yeon, (unknown), Sungjin Kim, James L. Mohler, Michael R. Freeman, Hyung L. Kim	26
6	Comprehensive palmitoyl‐proteomic analysis identifies distinct protein signatures for large and small cancer‐derived extracellular vesicles 2020 ·Journal of Extracellular Vesicles ·Javier Mariscal, Tatyana Vagner, Minhyung Kim, Bo Zhou, Andrew R. Chin, Mandana Zandian, Michael R. Freeman, Sungyong You, Andries Zijlstra, Wei Yang, Dolores Di Vizio	56
7	MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer 2017 ·Cancer Research ·Valentina R. Minciacchi, Cristiana Spinelli, Mariana Reis-Sobreiro, Lorenzo Cavallini, Sungyong You, Mandana Zandian, Xiaohong Li, Rajeev Mishra, Paola Chiarugi, Rosalyn M. Adam, Edwin M. Posadas, Giuseppe Viglietto, Michael R. Freeman, Emanuele Cocucci, Neil A. Bhowmick, Dolores Di Vizio	120
8	CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer 2017 ·Cancer Research ·Mahmoud A. Alfaqih, Erik R. Nelson, Wen Liu, Rachid Safi, (unknown), Everardo Macias, Joseph Geradts, J. Will Thompson, Laura G. Dubois, Michael R. Freeman, Ching‐yi Chang, Jen‐Tsan Chi, Donald P. McDonnell, Stephen J. Freedland	89
9	Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome 2016 ·Cancer Research ·Sungyong You, Beatrice S. Knudsen, Nicholas Erho, Mohammed Alshalalfa, Mandeep Takhar, Hussam Al-Deen Ashab, Elai Davicioni, R. Jeffrey Karnes, Eric A. Klein, Robert B. Den, Ashley E. Ross, Edward M. Schaeffer, Isla P. Garraway, Jayoung Kim, Michael R. Freeman	132
10	RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization 2014 ·Endocrine Related Cancer ·Gina Chia‐Yi Chu, Haiyen E. Zhau, Ruoxiang Wang, André Rogatko, Feng Xu, Majd Zayzafoon, Youhua Liu, Mary C. Farach‐Carson, Sungyong You, Jayoung Kim, Michael R. Freeman, Leland W.K. Chung	68
11	Can Stroma Reaction Predict Cancer Lethality? 2013 ·Clinical Cancer Research ·Michael R. Freeman, Quanlin Li, Leland W.K. Chung	19
12	MST1 Is a Multifunctional Caspase-Independent Inhibitor of Androgenic Signaling 2011 ·Cancer Research ·Bekir Cinar, (unknown), (unknown), Seçkin Akgül, Nishit K. Mukhopadhyay, Murat Kiliçarslan, Daniel Gioeli, Michael R. Freeman	34
13	The Complex Interplay Between Cholesterol and Prostate Malignancy 2011 ·Urologic Clinics of North America ·Keith R. Solomon, Michael R. Freeman	60
14	Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease 2009 ·Cancer Research ·Dolores Di Vizio, Jayoung Kim, Martin H. Hager, Matteo Morello, Wei Yang, Christopher J. Lafargue, Lawrence D. True, Mark A. Rubin, Rosalyn M. Adam, Rameen Beroukhim, Francesca Demichelis, Michael R. Freeman	334
15	Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation 2009 ·Cancer Research ·Nishit K. Mukhopadhyay, Jayoung Kim, Bekir Cinar, Aruna Ramachandran, Martin H. Hager, Dolores Di Vizio, Rosalyn M. Adam, Mark A. Rubin, Pradip Raychaudhuri, Arrigo De Benedetti, Michael R. Freeman	56
16	Cholesterol Sensitivity of Endogenous and Myristoylated Akt 2007 ·Cancer Research ·Rosalyn M. Adam, Nishit K. Mukhopadhyay, Jayoung Kim, Dolores Di Vizio, Bekir Cinar, Kelly Boucher, Keith R. Solomon, Michael R. Freeman	107
17	Post-Transcriptional Regulation of the Androgen Receptor by Mammalian Target of Rapamycin 2005 ·Cancer Research ·Bekir Cinar, Arrigo De Benedetti, Michael R. Freeman	59
18	Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts 2005 ·Journal of Clinical Investigation ·Liyan Zhuang, Jayoung Kim, Rosalyn M. Adam, Keith R. Solomon, Michael R. Freeman	416
19	Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction. 1999 ·PubMed ·Joseph G. Borer, Jeong Mi Park, Anthony Atala, Hiep T. Nguyen, Rosalyn M. Adam, Alan B. Retik, Michael R. Freeman	27
20	Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. 1997 ·Journal of Clinical Investigation ·Michael R. Freeman, James J. Yoo, Gerhard Raab, Shay Söker, Rosalyn M. Adam, Francis X. Schneck, Andrew A. Renshaw, Michael Klagsbrun, Anthony Atala	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact